Overview

The Safety and PK Characteristics of the Co-administration of JLP-2002 and Comparator in Healthy Volunteers

Status:
Completed
Trial end date:
2021-05-26
Target enrollment:
Participant gender:
Summary
A randomized, open-label, single-dose, replicate crossover study to compare the pharmacokinetics and safety in healthy adult volunteers following oral administration of JLP-2002
Phase:
Phase 1
Details
Lead Sponsor:
Jeil Pharmaceutical Co., Ltd.